Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Richard M. Trosch"'
Publikováno v:
Clinical Parkinsonism & Related Disorders, Vol 3, Iss , Pp 100063- (2020)
Introduction: The efficacy and safety of abobotulinumtoxinA in the management of cervical dystonia has been established in randomized, controlled trials that use a selected trial population. In this meta-analysis of observational data, we evaluated t
Externí odkaz:
https://doaj.org/article/4d982e2d477f4640a6b910a3ba0297f8
Publikováno v:
Expert Review of Neurotherapeutics. 21:1125-1134
Introduction In patients with cervical dystonia (CD), pain is a major contributor to disability and social isolation and is often the main reason patients seek treatment. Surveys evaluating patient perceptions of their CD symptoms consistently highli
Autor:
Richard M. Trosch, Cynthia L. Comella, Stanley N. Caroff, William G. Ondo, Alicia C. Shillington, Brandon J. LaChappelle, Robert A. Hauser, Christof U. Correll, Joseph H. Friedman
Publikováno v:
CNS Spectrums. 28:219-219
ObjectivesCurrently utilized clinician-rated symptom scales for tardive dyskinesia (TD) have not kept up with the expanding spectrum of TD phenomenology. The objective of this study was to develop and test the reliability of a new instrument, the CTI
Publikováno v:
Movement Disorders. 22:1258-1264
Ojbective Evaluate the safety of botulinum toxin type B (BoNT-B) in subjects with hemifacial spasm (HFS). Methods This open-label, sequential dose-escalation study evaluated BoNT-B in subjects with HFS. Eligible subjects were enrolled and received a
Autor:
Richard M. Trosch
Publikováno v:
Journal of the American Geriatrics Society. 52:S266-S271
The neurological risks and benefits of atypical neuroleptics have received considerable attention in the medical literature, but there have been few controlled studies examining these risks in elderly patients. Well-designed, longterm prospective stu
Publikováno v:
Journal of the American Medical Directors Association. 4:H2-H7
Autor:
Christopher F. O'Brien, Meg C. Lannon, Lauren Seeberger, Rajesh Pahwa, Richard M. Trosch, William C. Koller, Joseph H. Friedman, Diane Smith, Peter A. LeWitt
Publikováno v:
Movement Disorders. 13:377-382
We conducted a multicentered, retrospective review of clozapine's (CZP) effects on a range of psychiatric, sleep, cognitive, motor, and sensory disorders in Parkinson's disease (PD). Therapeutic outcomes and adverse events were compared with varying
Publikováno v:
CNS drugs. 22(6)
Purpose: The outpatient follow-up phase of the apomorphine (APO) 303 study assessed the long-term efficacy and safety of intermittent subcutaneous apomorphine for ‘off’ episodes in patients with advanced Parkinson’s disease. Methods: We conduct
Autor:
Richard M, Trosch
Publikováno v:
Journal of the American Geriatrics Society. 52
Publikováno v:
Journal of the American Medical Directors Association. 4